Ursolic acid and carvacrol may be potential inhibitors of dormancy protein small heat shock protein16.3 of Mycobacterium tuberculosis

References

• Ahmad, I., Aqil, F., & Owais, M. (2006). Modern phytomedicine: Turning medicinal plants into drugs. Germany: Wiley VCH Verlag GmBH.10.1002/9783527609987
   Google Scholar
• Alokam, R., Jeankumar, V. U., Sridevi, J. P., Matikonda, S. S., Peddi, S., Alvala, M., … Sriram, D. (2014). Identification and structure-activity relationship study of carvacrol derivatives as Mycobacterium tuberculosis chorismate mutase inhibitors. Journal of Enzyme Inhibition and Medicinal Chemistry, 29, 547–554. doi:10.3109/14756366.2013.823958
   PubMed Web of Science ®Google Scholar
• Andrade-Ochoa, S., Nevárez-Moorillón, G. V., Sánchez-Torres, L. E., Villanueva-García, M., Sánchez-Ramírez, B. E., Rodríguez-Valdez, L. M., & Rivera-Chavira, B. E. (2015). Quantitative structure-activity relationship of molecules constituent of different essential oils with antimycobacterial activity against Mycobacterium tuberculosis and Mycobacterium bovis. BMC Complementary and Alternative Medicine, 15, 332. doi:10.1186/s12906-015-0858-2
   PubMed Web of Science ®Google Scholar
• Borsari, C., Ferrari, S., Venturelli, A., & Costi, M. P. (2017). Target-based approaches for the discovery of new antimycobacterial drugs. Drug Discovery Today, 22, 576–584. doi:10.1016/j.drudis.2016.11.014
   PubMed Web of Science ®Google Scholar
• Case, D. A., Cerutti, D. S., Cheatham, T. E., III, Darden, T. A., Duke, R. E., Giese, T. J., … Kollman, P. A. (2017). AMBER 2017. San Francisco, CA: University of California.
   Google Scholar
• Centre for Disease Control and Prevention. (2006). Emergence of Mycobacterium tuberculosis with extensive resistance to second-line drugs-worldwide, 2000–2004. Morbidity and Mortality Weekly Report, 55, 301–305.
   PubMedGoogle Scholar
• Chang, Z., Primm, T. P., Jakana, J., Lee, I. H., Serysheva, I., Chiu, W., … Quiocho, F. A. (1996). Mycobacterium tuberculosis 16-kDa antigen (Hsp16.3) functions as an oligomeric structure in vitro to suppress thermal aggregation. Journal of Biological Chemistry, 271, 7218–7223. doi:10.1074/jbc.271.12.7218
   PubMed Web of Science ®Google Scholar
• Checker, R., Sandur, S. K., Sharma, D., Patwardhan, R. S., Jayakumar, S., Kohli, V., … Sainis, K. B. (2012). Potent anti-inflammatory activity of ursolic acid, a triterpenoid antioxidant, is mediated through suppression of NF-κB, AP-1 and NF-AT. PLoS ONE, 7, e31318. doi:10.1371/journal.pone.0031318
   PubMed Web of Science ®Google Scholar
• Clark, M., Cramer, R. D., & Van Opdenbosch, N. (1989). Validation of the general purpose tripos 5.2 force field. Journal of Computational Chemistry, 10, 982–1012. doi:10.1002/jcc.540100804
   Web of Science ®Google Scholar
• Connolly, L. E., Edelstein, P. H., & Ramakrishnan, L. (2007). Why is long-term therapy required to cure tuberculosis? PLoS Medicine, 4, e120. doi:10.1371/journal.pmed.0040120
   PubMed Web of Science ®Google Scholar
• Cox, H., Kebede, Y., Allamuratova, S., Ismailov, G., Davletmuratova, Z., Byrnes, G., … Doshetov, D. (2006). Tuberculosis recurrence and mortality after successful treatment: Impact of drug resistance. PLoS Medicine, 3, e384. doi:10.1371/journal.pmed.0030384
   PubMed Web of Science ®Google Scholar
• Cunningham, A. F., & Spreadbury, C. L. (1998). Mycobacterial stationary phase induced by low oxygen tension: Cell wall thickening and localization of the 16-kilodalton α-crystallin homolog. Journal of Bacteriology, 180, 801–808.
   PubMed Web of Science ®Google Scholar
• D’Ambrosio, L., Centis, R., Sotgiu, G., Pontali, E., Spanevello, A., & Migliori, G. B. (2015). New anti-tuberculosis drugs and regimens: 2015 update. ERJ Open Research, 1, 10–2015. doi:10.1183/23120541.00010-2015
   Google Scholar
• European Parliament and Council. (1996). Regulation (EC) No 2232/96 the European Parliament, and of the Council on 28 October 1996,Commission Decision of 23 February 1999 adopting a register of flavouring substances used in or on food stuffs. Official Journal of the European Communities, L84:1999/217/EC, 1–37.
   Google Scholar
• Evangelopoulos, D., da Fonseca, J. D., & Waddell, S. J. (2015). Understanding anti-tuberculosis drug efficacy: Rethinking bacterial populations and how we model them. International Journal of Infectious Diseases, 32, 76–80. doi:10.1016/j.ijid.2014.11.028
   PubMed Web of Science ®Google Scholar
• Gajula, M. N. P., Kumar, A., & Ijaq, J. (2016). Protocol for molecular dynamics simulations of proteins. Bio-protocol, 6, 1–11. doi:10.21769/BioProtoc.2051
   PubMedGoogle Scholar
• Gengenbacher, M., & Kaufmann, S. H. (2012). Mycobacterium tuberculosis: Success through dormancy. FEMS Microbiology Reviews, 36, 514–532. doi:10.1111/j.1574-6976.2012.00331.x
   PubMed Web of Science ®Google Scholar
• Gomez, J. E., & McKinney, J. D. (2004). M. tuberculosis persistence, latency, and drug tolerance. Tuberculosis (Edinb), 84, 29–44. doi:10.1016/j.tube.2003.08.003
   PubMed Web of Science ®Google Scholar
• Gonçalves, M. A., Santos, L. S., Prata, D. M., Peixoto, F. C., da Cunha, E. F. F., & Ramalho, T. C. (2017). Optimal wavelet signal compression as an efficient alternative to investigate molecular dynamics simulations: Application to thermal and solvent effects of MRI probes. Theoretical Chemistry Accounts, 136, 15. doi: 10.1007/s00214-016-2037-z
   PubMed Web of Science ®Google Scholar
• Hu, Y., & Coates, A. R. (1999). Transcription of the stationary-phase-associated hspX gene of Mycobacterium tuberculosis is inversely related to synthesis of the 16-kilodalton protein. Journal of Bacteriology, 181, 1380–1387.
   PubMed Web of Science ®Google Scholar
• Hu, Y., Movahedzadeh, F., Stoker, N. G., & Coates, A. R. (2006). Deletion of the Mycobacterium tuberculosis α-crystallin-like hspX gene causes increased bacterial growth in vivo. Infection and Immunity, 74, 861–868. doi:10.1128/IAI.74.2.861-868.2006
   PubMed Web of Science ®Google Scholar
• Huo, S., Massova, I., & Kollman, P. A. (2002). Computational alanine scanning of the 1:1 Human growth hormone-receptor complex. Journal of Computational Chemistry, 23, 15–27. doi:10.1002/jcc.1153
   PubMed Web of Science ®Google Scholar
• Hyldgaard, M., Mygind, T., & Meyer, R. L. (2012). Essential oils in food preservation: Mode of action, synergies, and interactions with food matrix components. Frontiers in Microbiology, 3, 12. doi:10.3389/fmicb.2012.00012
   PubMed Web of Science ®Google Scholar
• Jakalian, A., Jack, D. B., & Bayly, C. I. (2002). Fast, efficient generation of high-quality atomic charges. AM1-BCC model: II. Parameterization and validation. Journal of Computational Chemistry, 23, 1623–1641. doi:10.1002/jcc.10128
   PubMed Web of Science ®Google Scholar
• Jee, B., Katoch, V. M., & Awasthi, S. K. (2008). Dissection of relationship between small heat shock proteins and mycobacterial diseases. Indian Journal of Leprosy, 80, 231–245.
   PubMedGoogle Scholar
• Jee, B., Sharma, P., Katoch, K., Joshi, B., & Sudhir, S. K. (2017). IL-10 down-regulates the expression of survival associated gene hspX of Mycobacterium tuberculosis in murine macrophage. Brazilian Journal of Infectious Diseases, 21, 386–390. doi:10.1016/j.bjid.2017.03.009
   PubMed Web of Science ®Google Scholar
• Jesus, J. A., Lago, J. H., Laurenti, M. D., Yamamoto, E. S., & Passero, L. F. (2015). Antimicrobial activity of oleanolic and ursolic acids: An update. Evidence-Based Complementary and Alternative Medicine, 2015, 620472. doi:10.1155/2015/620472
   PubMed Web of Science ®Google Scholar
• Jiménez-Arellanes, A., Luna-Herrera, J., Cornejo-Garrido, J., López-García, S., Castro-Mussot, M. E., Meckes-Fischer, M., … Hernández-Pando, R. (2013). Ursolic and oleanolic acids as antimicrobial and immunomodulatory compounds for tuberculosis treatment. BMC Complementary and Alternative Medicine, 13, 483. doi:10.1186/1472-6882-13-258
   Web of Science ®Google Scholar
• Jyoti, M. A., Nam, K. W., Jang, W. S., Kim, Y. H., Kim, S. K., Lee, B. E., & Song, H. Y. (2016). Antimycobacterial activity of methanolic plant extract of Artemisia capillaris containing ursolic acid and hydroquinone against Mycobacterium tuberculosis. Journal of Infection and Chemotherapy, 22, 200–208. doi:10.1016/j.jiac.2015.11.014
   PubMed Web of Science ®Google Scholar
• de Lima, W. E., Francisco, A., da Cunha, E. F., Radic, Z., Taylor, P., França, T. C., & Ramalho, T. C. (2017). Mechanistic studies of new oximes reactivators of human butyryl cholinesterase inhibited by cyclosarin and sarin. Journal of Biomolecular Structure and Dynamics, 35, 1272–1282. doi:10.1080/07391102.2016.1178173
   PubMed Web of Science ®Google Scholar
• López-García, S., Castañeda-Sanchez, J. I., Jiménez-Arellanes, A., Domínguez-López, L., Castro-Mussot, M. E., Hernández-Sanchéz, J., & Luna-Herrera, J. (2015). Macrophage activation by ursolic and oleanolic acids during mycobacterial infection. Molecules, 20, 14348–14364. doi:10.3390/molecules200814348
   PubMed Web of Science ®Google Scholar
• Maier, J. A., Martinez, C., Kasavajhala, K., Wickstrom, L., Hauser, K. E., & Simmerling, C. (2015). ff14SB: Improving the accuracy of protein side chain and backbone parameters from ff99SB. Journal of Chemical Theory and Computation, 11, 3696–3713. doi:10.1021/acs.jctc.5b00255
   PubMed Web of Science ®Google Scholar
• Melo, T. S., Gattass, C. R., Soares, D. C., Cunha, M. R., Ferreira, C., Tavares, M. T., … Delorenzi, J. C. (2016). Oleanolic acid (OA) as an antileishmanial agent: Biological evaluation and in silico mechanistic insights. Parasitology International, 65, 227–237. doi:10.1016/j.parint.2016.01.001
   PubMed Web of Science ®Google Scholar
• Nguta, J. M., Appiah-Opong, R., Nyarko, A. K., Yeboah-Manu, D., & Addo, P. G. (2015). Current perspectives in drug discovery against tuberculosis from natural products. International Journal of Mycobacteriology, 4, 165–183. doi:10.1016/j.ijmyco.2015.05.004
   PubMed Web of Science ®Google Scholar
• Niu, H., Hu, L., Li, Q., Da, Z., Wang, B., Tang, K., … Zhu, B. (2011). Construction and evaluation of a multistage Mycobacterium tuberculosis subunit vaccine candidate Mtb10.4-HspX. Vaccine, 29, 9451–9458. doi:10.1016/j.vaccine.2011.10.032
   PubMed Web of Science ®Google Scholar
• Podder, B., Jang, W. S., Nam, K. W., Lee, B. E., & Song, H. Y. (2015). Ursolic acid activates intracellular killing effect of macrophages during Mycobacterium tuberculosis infection. Journal of Microbiology and Biotechnology, 25, 738–744.10.4014/jmb.1407.07020
   PubMed Web of Science ®Google Scholar
• Powell, M. D. (1977). Restart procedures for the conjugate gradient method. Mathematical Programming, 12, 241–254. doi:10.1007/BF01593790
   Web of Science ®Google Scholar
• Pyle, M. M. (1947). Relative numbers of resistant tubercle bacilli in sputum of patients before and during treatment of streptomycin. Proceedings of Staff Meetings of Mayo Clinic, 22, 465–473.
   PubMed Web of Science ®Google Scholar
• Ramalho, T. C., Caetano, M. S., Josa, D., Luz, G. P., Freitas, E. A., & da Cunha, E. F. (2011). Molecular modeling of Mycobacterium tuberculosis dUTpase: Docking and catalytic mechanism studies. Journal of Biomolecular Structure and Dynamics, 28, 907–917. doi:10.1080/07391102.2011.10508617
   PubMed Web of Science ®Google Scholar
• Santhosh, R. S., & Suriyanarayanan, B. (2014). Plants: A source for new antimycobacterial drugs. Planta Medica, 80, 9–21. doi:10.1055/s-0033-1350978
   PubMed Web of Science ®Google Scholar
• Siddiqui, K. F., Amir, M., & Agrewala, J. N. (2011). Understanding the biology of 16 kDa antigen of Mycobacterium tuberculosis : Scope in diagnosis, vaccine design and therapy. Critical Reviews in Microbiology, 37, 349–357. doi:10.3109/1040841X.2011.606425
   PubMed Web of Science ®Google Scholar
• Sikkema, J., De Bont, J. M., & Poolman, B. (1995). Mechanisms of membrane toxicity of hydrocarbons. Microbiological Reviews, 59, 201–222.
   PubMedGoogle Scholar
• Smith, T., Wolff, K. A., & Nguyen, L. (2013). Molecular biology of drug resistance in Mycobacterium tuberculosis. Current Topics in Microbiology and Immunology, 374, 53–80. doi:10.1007/82_2012_279
   PubMed Web of Science ®Google Scholar
• Spitzer, R., & Jain, A. N. (2012). Surflex-dock: Docking benchmarks and real-world application. Journal of Computer-Aided Molecular Design, 26, 687–699. doi:10.1007/s10822-011-9533-y
   PubMed Web of Science ®Google Scholar
• Tsui, V., & Case, D. A. (2001). Calculations of the absolute free energies of binding between RNA and metal ions using molecular dynamics simulations and continuum electrostatics. The Journal of Physical Chemistry B, 105, 11314–11325. doi:10.1021/jp011923z
   Web of Science ®Google Scholar
• U. S. Food and Drug Administration. (2006). Everything added to food in the United States: A food additive database. Washington, DC: Centre for Food Safety and Applied Nutrition.
   Google Scholar
• Wang, J., Wolf, R. M., Caldwell, J. W., Kollman, P. A., & Case, D. A. (2004). Development and testing of a general amber force field. Journal of Computational Chemistry, 25, 1157–1174. doi:10.1002/jcc.20035
   PubMed Web of Science ®Google Scholar
• Wang, J., Wang, W., Kollman, P. A., & Case, D. A. (2006). Automatic atom type and bond type perception in molecular mechanical calculations. Journal of Molecular Graphics and Modelling, 25, 247–260. doi:10.1016/j.jmgm.2005.12.005
   PubMed Web of Science ®Google Scholar
• World Health Organization. (2016). Global tuberculosis report. Geneva: WHO.
   Google Scholar
• Woźniak, Ł., Skąpska, S., & Marszałek, K. (2015). Ursolic acid – A pentacyclic triterpenoid with a wide spectrum of pharmacological activities. Molecules, 20, 20614–20641. doi:10.3390/molecules201119721
   PubMed Web of Science ®Google Scholar
• Yuan, Y., Crane, D. D., & Barry, C. E. I. I. I. (1996). Stationary phase-associated protein expression in Mycobacterium tuberculosis: Function of the mycobacterial alpha-crystallin homolog. Journal of Bacteriology, 178, 4484–4492. doi:10.1128/jb.178.15.4484-4492.1996
   PubMed Web of Science ®Google Scholar
• Yuan, Y., Crane, D. D., Simpson, R. M., Zhu, Y. Q., Hickey, M. J., Sherman, D. R., & Barry, C. E. I. I. I. (1998). The 16-kDa alpha-crystallin (Acr) protein of Mycobacterium tuberculosis is required for growth in macrophages. Proceedings of the National Academy of Sciences of United States of America, 95, 9578–9583.10.1073/pnas.95.16.9578
   PubMed Web of Science ®Google Scholar
• Zerin, T., Lee, M., Jang, W. S., Nam, K. W., & Song, H. Y. (2016). Anti-inflammatory potential of ursolic acid in Mycobacterium tuberculosis-sensitized and concanavalin A-stimulated cells. Molecular Medicine Reports, 13, 2736–2744. doi:10.3892/mmr.2016.4840
   PubMed Web of Science ®Google Scholar